INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $178,000 | -11.0% | 355,175 | -0.8% | 0.00% | – |
| Q4 2019 | $200,000 | -45.2% | 358,112 | +4.8% | 0.00% | – |
| Q3 2019 | $365,000 | -9.2% | 341,807 | -1.4% | 0.00% | – |
| Q2 2019 | $402,000 | -82.8% | 346,790 | -71.3% | 0.00% | – |
| Q1 2019 | $2,334,000 | -19.8% | 1,209,483 | -4.0% | 0.00% | – |
| Q4 2018 | $2,910,000 | -64.0% | 1,259,803 | +6.4% | 0.00% | – |
| Q3 2018 | $8,084,000 | -61.1% | 1,183,763 | +34.1% | 0.00% | -100.0% |
| Q2 2018 | $20,804,000 | +61088.2% | 882,621 | +71891.9% | 0.00% | – |
| Q1 2018 | $34,000 | – | 1,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |